We recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are going to take a look at where Compugen Ltd. (NASDAQ:CGEN) stands against other ...
Compugen Ltd. (NASDAQ: CGEN) Q4 2024 Earnings Call Transcript March 4, 2025 Compugen Ltd. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $0.07. Operator: Ladies and ...
Compugen (CGEN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.07. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for ...
Reports Q4 revenue $1.5M, consensus $17.47M. Expects current cash will be sufficient to fund its operating plans into 2027. “I believe Compugen (CGEN) is well-positioned for growth, building on ...
HOLON, Israel, Feb. 18, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results